Why Taking a GLP-1 Isn’t ‘Cheating’ — A Physician’s Perspective
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
Online forums have been busy lately with a familiar argument: people using GLP-1 medications like semaglutide or tirzepatide are being told, in comment sections and at dinner tables, that they’re taking the ‘easy way out.’ One thread comparing this judgment to guilt over natural animal behavior struck a nerve, racking up dozens of replies. As a physician, I want to step back from the debate and talk about where this stigma comes from — and why it doesn’t hold up medically.
The ‘Willpower’ Myth
For decades, obesity was treated as a character issue rather than a medical one. If someone struggled with their weight, the assumption was they simply hadn’t tried hard enough. We now understand this framing was incomplete. Body weight regulation involves hormones, appetite signaling, genetics, sleep, stress physiology, and metabolic history — factors largely outside conscious control. GLP-1 medications work by influencing some of these same hormonal pathways, the ones that regulate hunger and fullness. That’s not bypassing effort. It’s addressing biology.
We Don’t Say This About Other Conditions
Nobody accuses a patient with high blood pressure of ‘cheating’ by taking lisinopril instead of controlling it through sheer discipline. We don’t tell someone with hypothyroidism to try harder before prescribing levothyroxine. Obesity is one of the few chronic conditions where medical treatment is still met with moral judgment instead of clinical acceptance. That inconsistency says more about lingering cultural attitudes than it does about the medicine itself.
Medication Is a Tool, Not a Shortcut
It’s worth being honest here: GLP-1 medications are not a passive fix. Patients on semaglutide or tirzepatide still make daily decisions about food, movement, and health habits — the medication changes the physiological environment those decisions happen in, particularly around hunger and satiety. Describing this as ‘the easy way’ misunderstands both the medication and the ongoing effort patients put in during treatment. It also ignores the medical supervision, lab monitoring, and dose adjustments involved in responsible use.
Stigma Has Real Consequences
The judgment patients describe online isn’t just an inconvenience — it can delay people from seeking care they medically qualify for, or make them hide treatment from friends and family. In my experience, patients sometimes carry more anxiety about being judged for treatment than about the treatment itself. That’s a problem worth naming directly. Chronic disease management shouldn’t require secrecy.
What This Means for Patients
If you’re considering whether a GLP-1 medication is appropriate for your health, that conversation belongs between you and a physician who can review your full medical history — not in a comment thread. Every treatment decision should be individualized, medically supervised, and based on your actual health picture, not on public opinion about what counts as ‘earning’ results.
Have a real conversation with a physician about whether semaglutide or tirzepatide fits your health history and goals — no judgment, just medicine. Talk to a physician →
